Bone protection mechanism of Zuogui Pill in an osteoporosis model of breast cancer rats after endocrine therapy

Author:

ao youguang1,Chunhui Liu1,Lei Yao1,La Zhou1,Zhaolei Jiang1,Jianchao Ma1,Zhuorui Shen1

Affiliation:

1. Inner Mongolia Medical University

Abstract

Abstract Background Postmenopausal breast cancer patients treated with aromatase inhibitors (AIs) have an increased risk of developing secondary osteoporosis. Zuogui Pill has been proven to have obvious preventative and therapeutic effects against osteoporosis in the clinic. However, the possible mechanism of this bone-protective mechanism of Zuogui Pill is still largely unknown.Methods An osteoporosis model of postmenopausal breast cancer was generated by gavage of letrozole in ovariectomized mice with breast cancer. Serum oestradiol (E2), bone alkaline phosphatase (BALP), and amino terminal propeptide of type Ⅰ collagen (PINP) were detected by enzyme-related immunosorbent assays (ELISAs). After death, the right femur and tibia were taken and stained with HE to observe the bone histopathology. Microcomputed tomography (µCT) was used to detect bone density and trabecular microstructure in vitro. The protein expression levels of Wnt3a, β-catenin and Runx2 in bone tissue were detected by Western blots.Results Zuogui Pill significantly decreased the serum level of bone alkaline phosphatase (BALP) and the level of amino terminal procollagen Ⅰ propeptide (PINP) but had no significant effect on oestradiol (E2). Zuogui Pill improved bone tissue morphology, bone microstructure and bone mineral density. The protein expression levels of Wnt3a, β-catenin and Runx2 in the Zuogui Pill groups were significantly increased.Conclusion Zuogui Pill exerts a bone-protective effect through the Wnt/β-catenin and Wnt/Runx2 pathways and has good application value for the treatment of osteoporosis.

Publisher

Research Square Platform LLC

Reference23 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3